Wendy Montero Pérez has a bachelor’s degree in pharmaceutical sciences from Havana University. She works in the Department of Quality Assurance at the Center of Molecular Immunology in Havana.
Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseasesSparrow, E., M. Friede, M. Sheikh, and S. Torvaldsen. “Therapeutic Antibodies for Infectious Diseases.” Bulletin of the World Health Organization 95, no. 3 (2017):235–237. doi:10.2471/BLT.16.178061 and chronic conditions such as cancer